Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Accumulated Expenses (2024 - 2026)

Updated

Adaptin Bio's Accumulated Expenses came in at $810,589 for Q2 2026, up 55.4% from $521,656 a year earlier but down 6.8% from the prior quarter.

Analysis

Adaptin Bio (APTN) Accumulated Expenses (2024 - 2026) Analysis & Trends

At the end of FY2025, Adaptin Bio's Accumulated Expenses was $596,465, down 43.2% from FY2024.

  • Going back by year, Accumulated Expenses was $1.05 million in FY2024.
  • The five-year range for quarterly Accumulated Expenses is $521,656 (Q2 2025) to $1.05 million (Q4 2024).
  • Business Quant data shows APTN's Accumulated Expenses at $869,681 (Q1 2026), $596,465 (Q4 2025) and $522,476 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Adaptin Bio 56.76 Mn 54.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 810,589.00
Mar 31, 2026 869,681.00
Dec 31, 2025 596,465.00
Sep 30, 2025 522,476.00
Jun 30, 2025 521,656.00
Mar 31, 2025 781,683.00
Dec 31, 2024 1.05 Mn
API Access

Adaptin Bio Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=APTN&period=max&api_key=YOUR_API_KEY